Dimethyl fumarate #CAS624-49-7

CAS Number: 624-49-7

Chemical Formula: C6H8O4

  • Synonyms:

    • DiMethyl fuMarate, 99% 100GR

    • DiMethyl fuMarate, 99% 25GR

    • Fumaric acid, bis-methyl ester

      Appearance:White Powder

  • MOQ (Minimum Order Quantity): 1 FCL (Full Container Load)


Product Details

Dimethyl fumarate #CAS624-49-7

In March 2013, the US FDA approved dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis (MS). Dimethyl fumarate is the newest oral therapeutic for MS. While its mechanism is not completely understood, dimethyl fumarate increases anti-inflammatory cytokines (IL-10, IL-4, and IL-6), decreases proinflammatory cytokines (IL-1β, IL-6, and TNF-α), and activates the Nrf2 pathway to protect neuronal cells. Nrf2 is activated by covalent bond-forming electrophiles such as dimethyl fumarate, a Michael acceptor. Dimethyl fumarate has been used for the treatment of psoriasis in Europe since 1994 and has a favorable long-term safety profile. An exploratory study in patients with relapsing remitting MS showed significant reductions in MS lesions after 18 weeks of treatment with 720 mg/day of dimethyl fumarate. Evaluation of dimethyl fumarate in a mouse experimental autoimmune encephalomyelitis model of MS resulted in reduced spinal cord macrophage inflammation. Dimethyl fumarate is obtained in high purity by esterification of fumaric acid with methanol and catalytic sulfuric acid.

ChEBI: Dimethyl fumarate is an enoate ester resulting from the formal condensation of both carboxy groups of fumaric acid with methanol. Used for treatment of adults with relapsing forms of multiple sclerosis. It has a role as an immunomodulator and an antipsoriatic. It is an enoate ester, a methyl ester and a diester. It is functionally related to a methanol and a fumaric acid.

Dimethyl fumarate is a novel oral therapeutic agent, which can be used for patients suffering from relapsing-remitting multiple sclerosis. It shows an effective inhibition of mould in bread and can also serve as a potential candidate for the treatment of psoriasis, a chronic autoimmune condition.

Application of Dimethyl fumarate

Dimethyl fumarate acts as an immunomodulator. It is also used in cycloaddition reactions involving ylides, benzenes and amino acids. It is added to food grains,tobacco,leather and preservation. Clothing

Treatment of relapsing-remitting multiple sclerosis
Treatment of moderate to severe plaque psoriasis

Dimethyl fumarate Chemical Properties
Melting point 102-106 °C (lit.)
Boiling point 192-193 °C (lit.)
density 1,37 g/cm3
vapor pressure 5 hPa (25 °C)
refractive index 1.4062 (estimate)
Fp 192-193°C
storage temp. Store below +30°C.
solubility 1.6g/l
form Liquid
color Clear colorless to faintly yellow
PH4.0-6.0 (10g/l, H2O, 20℃)suspension
Water Solubility Soluble in water (1.6 mg/ml at 20°C), methanol (30-36 mg/ml), ethanol (10 mg/ml at 25°C), DMSO (29 mg/ml at 25°C), and DMF (~12 mg/ml).
Merck 14,4287
BRN 774590
Henry's Law Constant1.4×101 mol/(m3Pa) at 25℃, HSDB (2015)
Stability:Stable. Incompatible with acids, bases, oxidizing agents, reducing agents.
InChI1S/C6H8O4/c1-9-5(7)3-4-6(8)10-2/h3-4H,1-2H3/b4-3+
InChIKeyLDCRTTXIJACKKU-ONEGZZNKSA-N
SMILES[H]\C(=C(\[H])C(=O)OC)C(=O)OC
CAS DataBase Reference624-49-7(CAS DataBase Reference)
NIST Chemistry Reference2-Butenedioic acid (E)-, dimethyl ester(624-49-7)
EPA Substance Registry System2-Butenedioic acid (2E)-, 1,4-dimethyl ester (624-49-7)

Safety Information
Hazard Codes Xn
Risk Statements 21-38-41-43-36/37/38-36/38
Safety Statements 26-36/37/39-36/37
RIDADR UN 3077 9 / PGIII
WGK Germany 1
RTECS EM6125000
TSCA TSCA listed
HazardClass 9
HS Code 29171990
Storage Class11 - Combustible Solids
Hazard ClassificationsAcute Tox. 4 Dermal
Aquatic Chronic 2
Skin Irrit. 2
Skin Sens. 1
STOT SE 3
Hazardous Substances Data624-49-7(Hazardous Substances Data)
ToxicityLD50 orally in Rabbit: 2240 mg/kg LD50 dermal Rabbit 1250 mg/kg

Fact Factory and Equipment Show

Magnesium oxideCAS:1309-48-4

Leave your messages

Related Products

x

Popular products

x